Diabetic neuropathy and risk of diabetic foot syndrome during implementation of the national protocol in management of diabetes
No 2(8) (2016), Articles
No 2(8) (2016)

Diabetic neuropathy and risk of diabetic foot syndrome during implementation of the national protocol in management of diabetes

Articles
https://doi.org/10.33444/2411-5797.2016.2(8).44-51
Published June 20, 2016
V. Tkachenko
ARTICLE PDF

Keywords

diabetic neuropathy, diabetic foot syndrome, primary care, implementation of new clinical protocol

How to Cite

Tkachenko, V. (2016). Diabetic neuropathy and risk of diabetic foot syndrome during implementation of the national protocol in management of diabetes. East European Journal of Neurology, (2(8), 44-51. https://doi.org/10.33444/2411-5797.2016.2(8).44-51
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

The implementation of unified clinical protocol (UCP) has set a target to primary care physicians (PCP) to identify the diabetic neuropathy and angiopathy, screening the risk of diabetic foot syndrome and its prevention. The aim of our research - to determine the frequency of diabetic neuropathy, the risk of diabetic foot syndrome and level of type 2 diabetes control in patients of Kyiv region in terms of implementation of new clinical protocol in type 2 diabetes management. Materials and methods. The reports of health establishments of Kiev region were analyzed and 173 patients with type 2 diabetes were examined (aged 55,13 ± 0,61 years): group 1 - observed by PCP (n=45), group 2 - by endocrinologists (n=128). Patients examination included laboratory tests of diabetes control and evaluation of the lower limbs by Neuropathy Disability Score and determination the "ankle-shoulder" index with the portable Doppler. Statistical analysis - Excel 2007, SPSS, Statistica 6.0. Results. Despite treatment, the average levels of blood glucose, HbA1c, lipidogramme exceeded target levels in patients with type 2 diabetes, indicating their lack of control. In this regard, at 7-9 years of the disease in 19.65% of patients were founeded signs of severe and in 36.42% - moderate diabetic neuropathy of the lower limbs and in 15.03% of patients - occlusion, leading to the development of diabetic foot syndrome in 9.82% of patients, and 70.52% of the patients had moderate (44.51%) or high (26.01%) risk of its development. The differences between patients of PCP and endocrinologists were not found. However, the significant decrease of neuropathy and angiopathy of lower limbs in patients with type 2 diabetes in the Kiev region and reducing the number of amputations for 2012-2014 demonstrates the positive effect of the implementation of UCP. Conclusion. The frequency of diabetic neuropathy and angiopathy of lower limbs, the number of amputations in Kiev region decreased, that indicates a positive effect of implementation of UCP, but the risk of diabetic foot syndrome in patients remains high due to inadequate control of type 2 diabetes by patients and PC physicians and specialists that require optimization.

https://doi.org/10.33444/2411-5797.2016.2(8).44-51
ARTICLE PDF

References

1. International Diabetes Federation. Diabetes Atlas, Second edition, Brussels, Belgium: International Diabetes Federation.- 2015. – 144 p.
2. International Diabetes Federation. Diabetes Atlas, Second edition, Brussels, Belgium: International Diabetes Federation.- 2003. - 297p.
3. International Diabetes Federation. Diabetes Atlas, Sixth edition, Brussels, Belgium: International Diabetes Federation, 2013. – 162 p. Online version of IDF Diabetes Atlas: www.idf.org/diabetesatlas
4. Про затвердження та впровадження медико-технологічних документів зі стандартизації медичної допомоги при цукровому діабеті 2 типу : наказ МОЗ України від 21.12.2012 № 1118. - Режим доступу до док.: http://www.moz.gov.ua/ua/portal/dn_20121221_1118.html
5. Ткаченко В.І. Співвідношення альбумін-креатинін сечі та швидкість клубочкової фільтрації як фактори ризику серцево-судинної патології у хворих з цукровим діабетом 2 типу /В.І. Ткаченк //The Unity of Science. – 2015. – November. – С. 105-109.
6. Лисенко Г.І. Диспансеризація як шлях первинної і вторинної профілактики цукрового діабету 2-го типу на етапі первинної медичної допомоги (навчально-методичний посібник) / Г.І. Лисенко, В.І. Ткаченко. – К., 2013. – 144 с.
7. Ткаченко В.І. Розробка та впровадження уніфікованого та локального протоколів з надання медичної допомоги при цукровому діабеті 2 типу на етапі первинної медичної допомоги / В.І. Ткаченко // Методичні рекомендації. – Київ, 2014. – 94 с.
8. Порівняльний аналіз основних показників здоров’я населення та кадрового забезпечення діабетологічної допомоги в Київській області в умовах впровадження медико-технологічних документів (2010-12 рр. і 2012-2014 рр.) / В.І. Ткаченко, Б.М. Маньковський, Н.В. Видиборець, О.Ф Коваленко // Міжнародний ендокринологічний журнал. – 2015. – №5 (69). – С. 147-154.
9. Kailash Prasad. Reducing the Risk: Measures to Lower CRP in CVD / Kailash Prasad // Perspectives in Cardiology. - 2007, February. – Р. 31-34
10. Mora S, et al. The clinical utility of High-sensitivity C-reactive protein in Cardiovascular disease and the potential implication of JUPITER on Current practice // Guidelines clinical chemistry. – 2009. – Vol. 55. – P.2219-2228.
11. Rutter MK. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study / MK Rutter, JB Meigs, et al. // Circulation. – 2004. – Vol. 110. – Р.380-385.